When comparing Na[18F]F PET–CT and PSMA PET–CT, the investigators appreciated considerable discordance and revealed PSMA activity in prostate cancer metastases and bone turnover becomes weaker in more advanced stages of disease [31]. This evidence concerns the gene FOLH1 and prostate carcinoma.